SIGMAR1
Basic information
Region (hg38): 9:34634722-34637844
Previous symbols: [ "OPRS1" ]
Links
Phenotypes
GenCC
Source:
- amyotrophic lateral sclerosis type 16 (Moderate), mode of inheritance: AR
- autosomal recessive distal spinal muscular atrophy 2 (Supportive), mode of inheritance: AR
- juvenile amyotrophic lateral sclerosis (Supportive), mode of inheritance: AR
- autosomal recessive distal spinal muscular atrophy 2 (Strong), mode of inheritance: AR
- amyotrophic lateral sclerosis type 16 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Amyotrophic lateral sclerosis 16, juvenile; Frontotemporal lobar degeneration-motor neuron disease; Neuronopathy, distal hereditary motor, autosomal recessive 2 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 18755042; 21031579; 21842496; 26078401 |
ClinVar
This is a list of variants' phenotypes submitted to
- Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 (5 variants)
- Amyotrophic lateral sclerosis type 16;Autosomal recessive distal spinal muscular atrophy 2 (4 variants)
- Amyotrophic lateral sclerosis type 16 (2 variants)
- Inborn genetic diseases (2 variants)
- Autosomal recessive distal spinal muscular atrophy 2 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SIGMAR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 44 | 46 | ||||
missense | 74 | 81 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 7 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 6 | 1 | 9 | ||
non coding | 16 | 22 | ||||
Total | 10 | 6 | 79 | 61 | 8 |
Highest pathogenic variant AF is 0.0000263
Variants in SIGMAR1
This is a list of pathogenic ClinVar variants found in the SIGMAR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-34635581-C-A | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Uncertain significance (Nov 11, 2020) | ||
9-34635591-CGCTCCTGTCTATCCGCAGGTCTTCCTTCAGGCCTGGCTGGTCAAGGGTCCTGGCCAAAGAGGTAGGTGGTGAGCTCAAGCCGGAGGCCCCGAGCATAGGAGCGAAGAGTATAGAAGAGGGTGAGGAAGTCCTGGGTGCTGAAGACAGTGTCGGCCAGCGCGAAGGCCAGGGTGGATGGGATGACGCCCCGGCCGTACTCCACCATCCATGTGTTTGGCCCCCACTCCACAGCTGTTGCCTCACCAGGCCCGTGTACTACCGTCTCCCCTGGGGGACAGGGAGCACCCAAGTG-C | Amyotrophic lateral sclerosis type 16 | Likely pathogenic (-) | ||
9-34635601-T-C | Amyotrophic lateral sclerosis type 16 • Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 • Autosomal recessive distal spinal muscular atrophy 2 | Benign (Jan 24, 2024) | ||
9-34635605-C-T | Likely benign (Sep 16, 2020) | |||
9-34635644-G-A | Amyotrophic lateral sclerosis type 16;Autosomal recessive distal spinal muscular atrophy 2 | Likely benign (Nov 14, 2023) | ||
9-34635646-CAA-C | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Uncertain significance (Aug 26, 2021) | ||
9-34635652-G-A | Amyotrophic lateral sclerosis type 16;Autosomal recessive distal spinal muscular atrophy 2 | Uncertain significance (Oct 12, 2019) | ||
9-34635665-C-T | Amyotrophic lateral sclerosis type 16;Autosomal recessive distal spinal muscular atrophy 2 | Likely benign (Oct 01, 2023) | ||
9-34635667-C-T | Amyotrophic lateral sclerosis type 16 | Likely pathogenic (Feb 02, 2022) | ||
9-34635672-C-T | Amyotrophic lateral sclerosis type 16;Autosomal recessive distal spinal muscular atrophy 2 • Inborn genetic diseases | Conflicting classifications of pathogenicity (Dec 30, 2023) | ||
9-34635673-G-A | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Uncertain significance (Oct 13, 2023) | ||
9-34635677-G-T | Amyotrophic lateral sclerosis type 16;Autosomal recessive distal spinal muscular atrophy 2 | Likely benign (Sep 20, 2018) | ||
9-34635678-C-T | Uncertain significance (Apr 11, 2023) | |||
9-34635681-C-G | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Uncertain significance (Jul 21, 2022) | ||
9-34635681-C-T | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Uncertain significance (Jan 02, 2024) | ||
9-34635682-G-A | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 • not specified | Benign/Likely benign (Jan 29, 2024) | ||
9-34635686-A-G | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Likely benign (Apr 25, 2023) | ||
9-34635687-T-G | Inborn genetic diseases | Uncertain significance (Apr 13, 2021) | ||
9-34635690-G-A | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Uncertain significance (Jun 03, 2022) | ||
9-34635699-G-A | Uncertain significance (Jun 07, 2022) | |||
9-34635704-G-A | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Likely benign (Jan 20, 2023) | ||
9-34635709-G-A | Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 • Inborn genetic diseases | Uncertain significance (Sep 02, 2021) | ||
9-34635727-TGCTGAAGACAGTGTCG-T | Amyotrophic lateral sclerosis type 16 • Autosomal recessive distal spinal muscular atrophy 2;Amyotrophic lateral sclerosis type 16 | Conflicting classifications of pathogenicity (Apr 08, 2022) | ||
9-34635729-C-T | Amyotrophic lateral sclerosis type 16;Autosomal recessive distal spinal muscular atrophy 2 | Uncertain significance (Apr 09, 2021) | ||
9-34635733-A-G | Amyotrophic lateral sclerosis type 16;Autosomal recessive distal spinal muscular atrophy 2 | Uncertain significance (May 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SIGMAR1 | protein_coding | protein_coding | ENST00000277010 | 4 | 3088 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.168 | 0.820 | 125720 | 0 | 8 | 125728 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.46 | 85 | 132 | 0.642 | 0.00000736 | 1389 |
Missense in Polyphen | 36 | 53.852 | 0.6685 | 620 | ||
Synonymous | 0.657 | 52 | 58.4 | 0.891 | 0.00000328 | 467 |
Loss of Function | 2.15 | 3 | 10.5 | 0.285 | 4.60e-7 | 99 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000129 | 0.000129 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000360 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions in lipid transport from the endoplasmic reticulum and is involved in a wide array of cellular functions probably through regulation of the biogenesis of lipid microdomains at the plasma membrane. Involved in the regulation of different receptors it plays a role in BDNF signaling and EGF signaling. Also regulates ion channels like the potassium channel and could modulate neurotransmitter release. Plays a role in calcium signaling through modulation together with ANK2 of the ITP3R-dependent calcium efflux at the endoplasmic reticulum. Plays a role in several other cell functions including proliferation, survival and death. Originally identified for its ability to bind various psychoactive drugs it is involved in learning processes, memory and mood alteration (PubMed:16472803, PubMed:9341151). Necessary for proper mitochondrial axonal transport in motor neurons, in particular the retrograde movement of mitochondria. Plays a role in protecting cells against oxidative stress-induced cell death via its interaction with RNF112 (By similarity). {ECO:0000250|UniProtKB:O55242, ECO:0000269|PubMed:16472803, ECO:0000269|PubMed:9341151}.;
- Disease
- DISEASE: Amyotrophic lateral sclerosis 16, juvenile (ALS16) [MIM:614373]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:21842496}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Distal spinal muscular atrophy, autosomal recessive, 2 (DSMA2) [MIM:605726]: An autosomal recessive neuromuscular disorder characterized by onset of distal muscle weakness and wasting affecting the lower and upper limbs in the first decade. There is no sensory involvement. {ECO:0000269|PubMed:26078401, ECO:0000269|PubMed:27629094}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in squamous cell - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.221
Intolerance Scores
- loftool
- 0.517
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 59.76
Haploinsufficiency Scores
- pHI
- 0.557
- hipred
- Y
- hipred_score
- 0.546
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.763
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sigmar1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- lipid transport;nervous system development;cell death in response to hydrogen peroxide;opioid receptor signaling pathway;regulation of neuron apoptotic process;protein homotrimerization
- Cellular component
- nuclear envelope;nuclear inner membrane;nuclear outer membrane;endoplasmic reticulum;endoplasmic reticulum membrane;lipid droplet;integral component of plasma membrane;postsynaptic density;integral component of membrane;cell junction;growth cone;cytoplasmic vesicle;postsynaptic membrane
- Molecular function
- opioid receptor activity;drug binding